Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis. Metz I, Rieckmann P, Kallmann B-A, Brück W Acta Neuropathol Commun. 2016; 4(1):81. Epub 2016 Aug 08. PMID: 27503238. Abstract CommentRecommendBookmarkWatch